Skip to main content
CivicGate

Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.

Energy and Commerce Committee · Health Subcommittee · House · Hearing · Jul 15, 2026 · 2123, Rayburn House Office Building

Video

Summary

No summary yet — a transcript has to be published before this proceeding can be summarised. Everything else on this page is already available.

Motions and votes

No recorded votes were published for this proceeding.

Witnesses (5)

  • Dr. Cynthia Verst President, Design and Delivery Innovation, R&D Solutions, IQVIA Written testimony ↗
  • Ms. Susan Winckler CEO, Reagan-Udall Foundation for the FDA Written testimony ↗
  • Dr. Aaron Kowalski CEO, Breakthrough T1D Written testimony ↗
  • Dr. Thomas Hwang Assistant Professor of Medicine, Brigham and Women's Hospital and Harvard Medical School Written testimony ↗
  • Mr. Thomas Bollyky Bloomberg Chair in Global Health, Senior Fellow for International Economics, Law, and Development; and Director of the Global Health Program, Council Written testimony ↗

Most witnesses are private citizens, academics and industry representatives who are not people CivicGate tracks — a name without a link is the normal case, not a missing record.

Members recorded

Congress.gov publishes no attendance list. These are the members named by the record itself — in an opening statement, in the transcript's attendance roster, or on a vote sheet. It is not necessarily everyone who attended.

Documents (29)

Source: the official Congress.gov record for this event — https://www.congress.gov/event/119th-Congress/house-event/119457. Committee record: Committee record.

← All proceedings